In this study, we systematically performed a comprehensive analysis of PELI1 across multiple tumor types using publicly available datasets to elucidate its expression patterns, clinical relevance, and oncogenic mechanisms, with further in-depth validation in LIHC. This evidence concerns the gene PELI1 and neoplasm.